{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T13:49:14Z","timestamp":1788961754418,"version":"build-2803163510"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Recently, severe manifestations associated with coronavirus disease 2019 (COVID-19) called multisystem inflammatory syndrome in children (MIS-C) have been recognized. Analysis of studies for this novel syndrome is needed for a better understanding of effective management among affected children.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>An extensive search strategy was conducted by combining the terms multisystem inflammatory syndrome in children and coronavirus infection or using the term multisystem inflammatory syndrome in children in bibliographic electronic databases (PubMed, EMBASE, and CINAHL) and in preprint servers (BioRxiv.org and MedRxiv.org) following the Preferred Reporting Items for Systematic Reviews and Metaanalyses guidelines to retrieve all articles published from January 1, 2020, to July 31, 2020. Observational cross-sectional, cohort, case series, and case reports were included.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 328 articles were identified. Sixteen studies with 655 participants (3 months\u201320 years of age) were included in the final analysis. Most of the children in reported studies presented with fever, gastrointestinal symptoms, and Kawasaki Disease-like symptoms. Sixty-eight percent of the patients required critical care; 40% needed inotropes; 34% received anticoagulation; and 15% required mechanical ventilation. More than two-thirds of the patients received intravenous immunoglobulin and 49% received corticosteroids. Remdesivir and convalescent plasma were the least commonly utilized therapies. Left ventricular dysfunction was reported in 32% of patients. Among patients presenting with KD-like symptoms, 23% developed coronary abnormalities and 26% had circulatory shock. The majority recovered; 11 (1.7%) children died.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>This systematic review delineates and summarizes clinical features, management, and outcomes of MIS-C associated with SARS-CoV-2 infection. Although most children required intensive care and immunomodulatory therapies, favorable outcomes were reported in the majority with low-mortality rates.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000002888","type":"journal-article","created":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T16:01:00Z","timestamp":1600012860000},"page":"e340-e346","source":"Crossref","is-referenced-by-count":211,"title":["A Systematic Review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection"],"prefix":"10.1097","volume":"39","author":[{"given":"Ashlesha","family":"Kaushik","sequence":"first","affiliation":[{"name":"Division of Pediatric Infectious Diseases, UnityPoint Health at St. Luke\u2019s Regional Medical Center and Department of Pediatrics, University of Iowa Carver College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Gupta","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care, UnityPoint Health at St. Luke\u2019s Regional Medical Center, Sioux City, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangla","family":"Sood","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Indira Gandhi Medical College, Shimla"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Dr. Rajendra Prasad Government Medical College, Kangra, Himachal Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikha","family":"Verma","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Dr. Rajendra Prasad Government Medical College, Kangra, Himachal Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,9,8]]},"reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"e20200702","DOI":"10.1542\/peds.2020-0702","article-title":"Epidemiology of COVID-19 among children in China.","volume":"145","author":"Dong","year":"2020","journal-title":"Pediatrics"},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"422","DOI":"10.15585\/mmwr.mm6914e4","article-title":"Coronavirus disease 2019 in children\u2014United States, February 12\u2013April 2, 2020.","volume":"69","author":"Bialek","year":"2020","journal-title":"Morb Mortal Wkly Rep"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(20)31094-1","article-title":"Hyperinflammatory shock in children during COVID-19 pandemic.","volume":"395","author":"Riphagen","year":"2020","journal-title":"Lancet"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(20)31103-X","article-title":"An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study.","volume":"395","author":"Verdoni","year":"2020","journal-title":"Lancet"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"e20201711","DOI":"10.1542\/peds.2020-1711","article-title":"SARS-CoV-2-induced Kawasaki-like hyperinflammatory syndrome: a novel COVID phenotype in children.","volume":"146","author":"Licciardi","year":"2020","journal-title":"Pediatrics"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/jama.2020.10374","article-title":"Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York city.","volume":"324","author":"Cheung","year":"2020","journal-title":"JAMA"},{"key":"R9-20230912","article-title":"Multisystem inflammatory syndrome in children (MIS-C) related to COVID-19: a New York city experience. [published online ahead of print, 2020 Jun 25].","author":"Riollano-Cruz","year":"2020","journal-title":"J Med Virol"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group.","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"12","author":"von Elm","year":"2014","journal-title":"Int J Surg"},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","article-title":"Methodological quality and synthesis of case series and case reports.","volume":"23","author":"Murad","year":"2018","journal-title":"BMJ Evid Based Med"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jpeds.2020.06.045","article-title":"Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2 infection: a multi-institutional study from New York city.","volume":"224","author":"Kaushik","year":"2020","journal-title":"J Pediatr"},{"key":"R15-20230912","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/jpids\/piaa069","article-title":"Multisystem inflammatory syndrome in children during the coronavirus 2019 pandemic: a case series.","volume":"9","author":"Chiotos","year":"2020","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R16-20230912","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jpeds.2020.06.044","article-title":"Characteristics, cardiac involvement, and outcomes of multisystem inflammatory syndrome of childhood associated with severe acute respiratory syndrome coronavirus 2 infection.","volume":"224","author":"Capone","year":"2020","journal-title":"J Pediatr"},{"key":"R17-20230912","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2020.05.117","article-title":"Toxic shock-like syndrome and COVID-19: a case report of multisystem inflammatory syndrome in children (MIS-C)","author":"Greene","year":"2020","journal-title":"Am J Emerg Med"},{"key":"R18-20230912","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa2021756","article-title":"Multisystem inflammatory syndrome in children in New York state.","volume":"383","author":"Dufort","year":"2020","journal-title":"N Engl J Med"},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJMoa2021680","article-title":"Multisystem inflammatory syndrome in U.S. children and adolescents.","volume":"383","author":"Feldstein","year":"2020","journal-title":"N Engl J Med"},{"key":"R20-20230912","article-title":"Gastrointestinal symptoms as a major presentation component of a novel multisystem inflammatory syndrome in children (MIS-C) that is related to COVID-19: a single center experience of 44 cases. [published online ahead of print, 2020 Jun 4].","author":"Miller","year":"2020","journal-title":"Gastroenterology"},{"key":"R21-20230912","first-page":"141113","article-title":"Distinct clinical and immunological features of SARS-COV-2-induced multisystem inflammatory syndrome in children [published online ahead of print, 2020 Jul 23].","author":"Lee","year":"2020","journal-title":"J Clin Invest"},{"key":"R22-20230912","doi-asserted-by":"crossref","first-page":"pii=2001010","DOI":"10.2807\/1560-7917.ES.2020.25.22.2001010","article-title":"SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020.","volume":"25","author":"Belot","year":"2020","journal-title":"Euro Surveill"},{"key":"R23-20230912","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/jama.2020.10369","article-title":"Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2.","volume":"324","author":"Whittaker","journal-title":"JAMA"},{"key":"R24-20230912","first-page":"ciaa1042","article-title":"Multi-inflammatory syndrome in children related to SARS-CoV-2 in Spain. [published online ahead of print, 2020 Jul 25].","author":"Moraleda","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R25-20230912","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s13312-020-1901-z","article-title":"Hyper-inflammatory syndrome in a child with COVID-19 treated successfully with intravenous immunoglobulin and tocilizumab.","volume":"57","author":"Balasubramanian","year":"2020","journal-title":"Indian Pediatr"},{"key":"R26-20230912","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s12098-020-03357-1","article-title":"Multisystem inflammatory syndrome with features of atypical Kawasaki disease during COVID-19 pandemic.","volume":"87","author":"Rauf","year":"2020","journal-title":"Indian J Pediatr"},{"key":"R27-20230912","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s13312-020-1924-5","article-title":"Novel coronavirus mimicking Kawasaki disease in an infant.","volume":"57","author":"Acharyya","year":"2020","journal-title":"Indian Pediatr"},{"key":"R28-20230912","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review [published online ahead of print, 2020 Apr 22].","author":"Castagnoli","year":"2020","journal-title":"JAMA Pediatr"},{"key":"R29-20230912","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China.","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"R30-20230912"},{"key":"R32-20230912","doi-asserted-by":"crossref","first-page":"e783","DOI":"10.1542\/peds.2008-1871","article-title":"Recognition of a Kawasaki disease shock syndrome.","volume":"123","author":"Kanegaye","year":"2009","journal-title":"Pediatrics"},{"key":"R33-20230912","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/jpids\/piaa062","article-title":"Pediatric coronavirus disease-2019-associated multisystem inflammatory syndrome.","volume":"9","author":"Shulman","year":"2020","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R34-20230912","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fphar.2017.00163","article-title":"IL-1 inhibition may have an important role in treating refractory Kawasaki disease.","volume":"8","author":"Dusser","year":"2017","journal-title":"Front Pharmacol"},{"key":"R36-20230912","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1473-3099(20)30141-9","article-title":"Convalescent plasma as a potential therapy for COVID-19.","volume":"20","author":"Chen","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"R37-20230912","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejim.2020.05.019","article-title":"Why should we use convalescent plasma for COVID-19?.","volume":"77","author":"Franchini","year":"2020","journal-title":"Eur J Intern Med"},{"key":"R38-20230912","article-title":"American College of Rheumatology Clinical Guidance for pediatric patients with multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2 and hyperinflammation in COVID-19. Version 1. [published online ahead of print, 2020 Jul 23].","author":"Henderson","year":"2020","journal-title":"Arthritis Rheumatol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002888","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:53:09Z","timestamp":1694559189000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,8]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002888","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,8]]}}}